Mifepristone efficacious for adenomyosis
For patients with adenomyosis, mifepristone is efficacious and has acceptable tolerability, according to a study published online June 12 in JAMA Network Open.
Jun 14, 2023
0
49
MeSH tree: D09.400.430.900.631
For patients with adenomyosis, mifepristone is efficacious and has acceptable tolerability, according to a study published online June 12 in JAMA Network Open.
Jun 14, 2023
0
49
Researchers at the Department of Obstetrics and Gynecology, Peking University Third Hospital in Beijing, China, have developed a new ovarian cancer screening technique. In a paper, "Profiling the metabolome of uterine fluid ...
One of the ways that cancer cells hide from the body's immune system is by forming a thin surface barrier called the glycocalyx. In a new study, researchers examined the material properties of this barrier with unprecedented ...
Mar 27, 2023
0
45
Molecules from mucus can be used to produce synthetic bone graft material and help with the healing of larger bone loss, a new study found.
Feb 7, 2023
0
52
In the United States, turning 45 brings with it a rather unpleasant rite of passage: the beginning of regular colonoscopies, in which an endoscope equipped with a light and a camera is used to visually check the colon for ...
Jan 19, 2023
0
78
A new way to prevent pregnancy without side effects may be possible with a prophylactic gel made from all natural, non-hormonal ingredients, scientists in Sweden report. The gel reinforces the cervical mucus barrier, offering ...
Nov 30, 2022
0
54
Regularly monitoring women with faulty BRCA genes that make them highly susceptible to ovarian cancer results in earlier stage diagnosis in those who want to defer preventive surgery, finds research published online in the ...
Nov 1, 2022
0
75
Ulcerative colitis is the most common type of inflammatory bowel disease, characterized by chronic ulcers and inflammation in the colon and rectum. Symptoms can be lifelong and range from mild to life-threatening. There is ...
Oct 18, 2022
0
173
Cow mucus provides the basis for a synthetic prophylactic gel developed at KTH Royal Institute of Technology to protect against HIV and herpes transmission. The lubricating gel proved 70% effective in lab tests against HIV, ...
Sep 15, 2022
0
135
Researchers have taken an important step toward understanding the microscopic battle that plays out between our lung cells and the SARS-CoV-2 virus that causes COVID-19. A UC Berkeley-led study has identified specific proteins ...
Jul 27, 2022
0
91